71 related articles for article (PubMed ID: 8725138)
1. Cytologic effects of photodynamic therapy in body fluids.
Garza OT; Abati A; Sindelar WF; Pass HI; Hijazi YM
Diagn Cytopathol; 1996 Jun; 14(4):356-61. PubMed ID: 8725138
[TBL] [Abstract][Full Text] [Related]
2. Cytopathologic differential diagnosis of malignant mesothelioma, adenocarcinoma and reactive mesothelial cells: A logistic regression analysis.
Cakir E; Demirag F; Aydin M; Unsal E
Diagn Cytopathol; 2009 Jan; 37(1):4-10. PubMed ID: 18973123
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
[TBL] [Abstract][Full Text] [Related]
4. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.
Schofield K; D'Aquila T; Rimm DL
Cancer; 1997 Oct; 81(5):293-8. PubMed ID: 9349517
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
6. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
7. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities.
Hornick JL; Mino-Kenudson M; Lauwers GY; Liu W; Goyal R; Odze RD
Am J Gastroenterol; 2008 Jan; 103(1):38-47. PubMed ID: 18076737
[TBL] [Abstract][Full Text] [Related]
8. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
[TBL] [Abstract][Full Text] [Related]
10. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
12. A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions.
Holloway AJ; Diyagama DS; Opeskin K; Creaney J; Robinson BW; Lake RA; Bowtell DD
Clin Cancer Res; 2006 Sep; 12(17):5129-35. PubMed ID: 16951230
[TBL] [Abstract][Full Text] [Related]
13. Cytologic criteria used to diagnose adenocarcinoma in pleural effusions.
Bottles K; Reznicek MJ; Holly EA; Ahn DK; Layfield LJ; Cohen MB
Mod Pathol; 1991 Nov; 4(6):677-81. PubMed ID: 1788258
[TBL] [Abstract][Full Text] [Related]
14. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma.
Ris HB
Lung Cancer; 2005 Jul; 49 Suppl 1():S65-8. PubMed ID: 15916831
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma.
Friedberg JS
Semin Thorac Cardiovasc Surg; 2009; 21(2):177-87. PubMed ID: 19822291
[TBL] [Abstract][Full Text] [Related]
18. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
19. Malignant-appearing cells in pleural effusion due to pancreatitis: case report and literature review.
Kutty CP; Remeniuk E; Varkey B
Acta Cytol; 1981; 25(4):412-6. PubMed ID: 6945008
[TBL] [Abstract][Full Text] [Related]
20. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]